Rapid effects of a biofield skin patch on antioxidant levels and cellular energy
Official title: Rapid Effects of a Biofield Patch on Antioxidant Status and Cellular Energy
Run by Natural Immune Systems Inc · NCT07314359 · Data updated 2026-11-12
This trial tests whether wearing an active biofield skin patch versus a placebo patch produces rapid changes in antioxidant enzymes, glutathione, mitochondrial function, and inflammatory markers in healthy adults.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 75 Years |
| Sex | All |
| Enrollment | 12 (estimated) |
| Sponsor | Natural Immune Systems Inc Academic / other |
| Drugs / interventions | Chemotherapy |
| Locations | 1 site (Klamath Falls, Oregon) |
| Status | Recruiting |
| Started | December 4, 2025 |
| Main results expected | July 2026 |
| Study ends | August 2026 |
| Registry record updated | January 2, 2026 |
| Trial ID | NCT07314359 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are healthy adults aged 18–75 with BMI 18.0–34.9 who have visible veins for multiple blood draws and can follow the study's dietary and activity restrictions.
✕Probably not a fit
People with recent cancer or chemotherapy, those taking prescription weight-loss or cholesterol-lowering medications, or those with acute serious illness are unlikely to qualify or benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, placebo-controlled crossover proof-of-concept study with an additional open-label week where participants wear the active patch daily before the final visit. Multiple blood samples will be taken to measure endogenous antioxidant protection (superoxide dismutase and glutathione), mitochondrial energy production and biogenesis in white blood cells under normal and ex vivo-stressed conditions, and cytokine levels in serum and serum-derived extracellular vesicles. The primary comparison is between the active non-transdermal photobiomodulating patch and a matched placebo patch to document acute biomarker changes. Participants are healthy adults who must follow pre-visit restrictions and have veins accessible for multiple draws.
Why it matters
Potential benefit: If successful, the patch could offer a noninvasive way to quickly enhance antioxidant defenses and mitochondrial resilience, potentially supporting recovery from oxidative stress.
How similar studies have gone: The non-transdermal biofield patch approach is largely novel with limited direct clinical evidence, although related photobiomodulation and antioxidant biomarker studies have reported mixed and preliminary findings.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Healthy adults; * Age 18 - 75 years (inclusive); * BMI between 18.0 and 34.9 (inclusive); * Veins easy to see in one or both arms (to allow for the multiple blood draws); * Willing to comply with study procedures, including: * Maintaining a consistent diet and lifestyle routine throughout the study, * Consistent habit of bland breakfasts on days of clinic visits, * Abstaining from exercising and nutritional supplements on the morning of a study visit, * Abstaining from use of coffee, tea, and soft drinks for at least one hour prior to a clinic visit; * Abstaining from music, candy, gum, computer/cell phone use (airplane mode is allowed), during clinic visits. Exclusion Criteria: * Cancer during past 12 months; * Chemotherapy during past 12 months; * Currently taking prescription weight loss drugs (such as semaglutide); * Currently taking cholesterol-lowering medication (for example: statins); * Currently experiencing intense stressful events/life changes; * Currently in intensive athletic training (such as marathon runners); * Currently taking anxiolytic, hypnotic, or anti-depressant prescription medication; * Immunization during past 6 months; * An unusual sleep routine (examples: working graveyard shift, irregular routine with frequent late nights, studying, partying); * Unwilling to maintain a constant intake of supplements over the duration of the study; * Anxiety about having blood drawn; * Pregnant, nursing, or trying to become pregnant; * Known allergies related to adhesive materials.
Where it's running
-
NIS Labs
Klamath Falls, Oregon, United States Recruiting
Study contacts
- Study coordinator: Giite S Jensen, PhD
- Email: gitte@nislabs.com
- Phone: 5418820112
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.